Promise of Synbiotic in Gut-Kidney Axis

Authors

  • Josephine Herwita Atepela Dokter Umum, Jakarta

DOI:

https://doi.org/10.55175/cdk.v51i1.617

Keywords:

Dysbiosis, gut-kidney axis, microbiota, synbiotic

Abstract

Human microbiota plays a role in protecting human health. Change in the microbial composition will lead to an imbalance between the beneficial and potentially harmful bacteria, leading to “dysbiosis”. The pathogenic interconnection between gut microbiota and kidney diseases is called the gut–kidney axis, which is implicated in a wide range of clinical manifestations such as CKD (chronic kidney disease), AKI (acute kidney injury), hypertension, nephrolithiasis, IgA nephropathy, hemodialysis, and peritoneal dialysis. Synbiotic, a mixture of probiotics and prebiotics are reported to be beneficial in human health via the gut-kidney axis.

Downloads

Download data is not yet available.

References

DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflammatory Bowel Dis. 2016;22(5):1137–50. DOI:10.1097/MIB.0000000000000750.

Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018;14(7):442–56. DOI: 10.1038/s41581-018-0018-2

Rukavina Mikusic NL, Kouyoumdzian NM, Choi MR. Gut microbiota and chronic kidney disease: Evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflügers Archiv - Eur J Physiol. 2020;472(3):303–20.

Stavropoulou E, Kantartzi K, Tsigalou C, Konstantinidis T, Romanidou G, Voidarou C, et al. Focus on the gut–kidney axis in health and disease. Front Med [Internet]. 2021;7. Available from: https://doi.org/10.3389/fmed.2020.620102.

Lydia A, Indra TA, Rizka A, Abdullah M. The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: A randomized controlled trial. BMC Nephrol. 2022;23(1):259.

Yu Z, Zhao J, Qin Y, Wang Y, Zhang Y, Sun S. Probiotics, Prebiotics, and synbiotics improve uremic, inflammatory, and gastrointestinal symptoms in end-stage renal disease with dialysis: A network meta-analysis of randomized controlled trials. Front Nutr [Internet]. 2022;9. Available from: https://doi.org/10.3389/fnut.2022.850425.

Zheng HJ, Guo J, Wang Q, Wang L, Wang Y, Zhang F, et al. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;61(4):577–98. DOI: 10.1080/10408398.2020.1740645

Pavan M. Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease. Minerva Urol Nefrol. 2016;68(2):222-6.

Dai Y, Quan J, Xiong L, Luo Y, Yi B. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: A systematic review and meta-analysis. Renal Failure 2022;44(1):862–80.

Published

02-01-2024

How to Cite

Atepela, J. H. (2024). Promise of Synbiotic in Gut-Kidney Axis. Cermin Dunia Kedokteran, 51(1), 51–54. https://doi.org/10.55175/cdk.v51i1.617